Request Deal Involvement
Arcutis Biotherapeutics completed the acquisition of Ducentis BioTherapeutics from LifeArc for $400m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Goodwin Procter
legal advisors
Covington & Burling
pr advisors
Mo PR
or
Principals
target
DUCENTIS BIOTHERAPEUTICS
bidder
ARCUTIS BIOTHERAPEUTICS
vendor
LIFEARC VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite